GPES extracts and benefits - NHS England Digital

Cardiovascular Disease Prevention Audit (CVDPREVENT Audit)

Level of data - Record level

Frequency - Quarterly

Are patients who have registered a type 1 opt-out included? No

Purpose and benefits

The CVDPREVENT Audit is a national primary care audit that supports the implementation of the NHS Long Term Plan, the annually negotiated GP Contract and the national CVD Prevention programme.

The aim of the CVDPREVENT Audit is to support professionally led quality improvement, optimising diagnosis and treatment of high-risk conditions to prevent heart attacks and strokes at scale. The CVDPREVENT Audit also aims to evaluate the national CVD Prevention programme and inform better decisions on its delivery. The data has and continues to help clinicians understand how well they are performing in the diagnosis and management of six high-risk conditions for CVD: atrial fibrillation, high blood pressure, high cholesterol, diabetes, non-diabetic hyperglycaemia and chronic kidney disease.

COVID-19 At Risk Patients v5

Level of data - Record-level

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

The objective of this collection is to, on an ongoing basis, identify patients registered at GP practices who may be more at risk of getting seriously ill with COVID-19 and who would be potentially eligible for treatment should they contract COVID-19.

Patients facing the greatest risk if they contract COVID-19 and/or at risk of complications from flu:

will be identified and known to health organisations
will have a greater awareness of the recommended treatment and vaccination options
will be able to follow clear advice
will be able to ask for help and support

If patients facing the greatest risk follow advice, it is hoped that this will contribute to the delay and mitigation of the spread of COVID-19 and save lives.

Organisations, including the Government, need to access this vital data to help plan, monitor and manage the national response to the COVID-19 pandemic, which will help save lives.

It also allows for service alignment between the approaches used for general population direct care and detained estates. This has the benefit of minimising the burden of data collection and reducing divergence of treatment approaches for patients within the general population and those within the criminal justice secure and detained estate.

COVID-19 At Risk Patients v5 Detained Estate

Level of data - Record-level

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

The objective of this collection is to, on an ongoing basis, identify patients registered on the Health and Justice Information System (HJIS) in England who may be more at risk of getting seriously ill with COVID-19 and who would be potentially eligible for treatment should they contract COVID-19.

Organisations, including the Government, need to access this vital data to help plan, monitor and manage the national response to the COVID-19 pandemic, which will help save lives.

It also allows for service alignment between the approaches used for general population direct care and detained estates. This has the benefit of minimising the burden of data collection and reducing divergence of treatment approaches for patients within the general population and those within the criminal justice secure and detained estate.

General Practice to Diabetic Retinopathy Screening (GP2DRS)

Level of data - Record-level

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

GP2DRS is a system which automates the sharing of patient information between GP practices and local diabetic eye screening programmes by extracting the information directly from GP clinical systems and removing the need for manual processing.

Benefits to patients:

prompt referral to screening programme upon diagnosis
prompt identification of changes in details, for example a change in address
prompt identification of deceased patients
clearer approach to patient consent to data transfer
prompt communication from Screening Programmes

Benefits to Screening Programmes:

identification of eligible patients
automatic rather than manual data collation
improved accuracy of patient register
validation of patients list
timely notification of deceased patients or patients who have left the screening programme area
improved alignment of data between general practice and the screening programme
reduce administration overhead

GP Contract Services: 6-in-1 Vaccination and Immunisation Programme

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England regarding the monthly uptake of the 6-in-1 infant vaccinations (the 6 conditions being: Diptheria, Hepatitis B, Haemophilus influenzae type b (Hib), Polio, Tetanus, Pertussis) and the two booster vaccines.

GP Contract Services: Childhood Seasonal Influenza Vaccination and Immunisation Programme

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England regarding the monthly uptake of childhood seasonal flu vaccinations. The aim of this service is to support commissioners in commissioning childhood influenza vaccination services from GP practices to protect patients who are most at risk of serious illness or death should they develop influenza and to reduce transmission of the infection. Practices are expected to meet the national ambitions for all patient cohorts as given in the annual flu letter.

GP Contract Services: Core Contract

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

All GP practices in England are offered the choice to participate in this service. The purpose of the service is to support NHS England in ensuring practices are meeting contractual requirements as set out in the GMS Contract Regulations. This service ensures standardised care and improved patient outcomes and provides the relevant management information to support practices and commissioners understand their performance and ensure they meet their core GMS contract requirements.

Formerly the GMS/Personal Medical Services (PMS) core contract data collection, this collection has been merged with Alcohol Related Risk Reduction and Dementia Data, allowing their retirement as standalone extractions. This extract incorporates aspects of the previous Named Accountable GP 2016-17 extraction, as well as new information on the identification and management of patients with frailty (at an aggregate level).

Alcohol Risk Reduction - supports direct payment to GP practices under the GMS contract and provides management information to NHS England regarding Alcohol Related Risk Reduction Scheme activity.

Dementia - supports the monitoring of diagnosis rates for dementia. Collecting dementia diagnosis data broken down by age and gender, as well as ethnicity group, allows NHS England to monitor dementia diagnosis rates at a more granular level. Collecting data on dementia care plans, dementia assessments, referral to memory clinics and prescription of antipsychotic drugs allows NHS England to demonstrate that patients are receiving the appropriate care where necessary.

GMS/PMS - a quality service which supports NHS England to ensure that practices are meeting the requirements agreed as part of the contract. This is also an important reporting tool to demonstrate that patients are receiving a quality service from their GP practice and to flag to commissioners and practices any patient that has not been allocated an accountable GP.

GP Contract Services: Hepatitis B Vaccination and Immunisation Programme

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England regarding the Hepatitis B vaccination programme.

GP Contract Services: Human Papillomavirus (HPV) Vaccination and Immunisation Programme

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England to support monitoring and understanding of the impact of the scheme on health outcomes.

GP Contract Services: Indicators no longer in the Quality and Outcomes Framework (INLIQ)

Level of data - Aggregated

Frequency - Annual

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

All GP practices in England are offered the choice to participate in this service. The data is primarily used for management information purposes as well as for wider usage to help support commissioning, planning and policy decisions.

This extract of data from GP clinical systems supports commissioners in commissioning seasonal influenza vaccination services from GP practices to protect patients who are most at risk of serious illness or death should they develop influenza and to reduce transmission of the infection. Practices are expected to meet the national ambitions for all patient cohorts as given in the annual flu letter. The seasonal flu programme allows for vaccinations of both registered and unregistered patients.

The data collection also supports direct payment to GP practices under the GMS contract and provides management information to NHS England regarding the Seasonal Flu vaccination programme.

GP Contract Services: Shingles Combined Vaccination and Immunisation Programme

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England.

GP Extraction Service (GPES) Data for Pandemic Planning and Research (GDPPR)

Level of data - Record-level

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? No

Purpose and benefits

Data is analysed and shared by NHS England for COVID-19 research purposes including:

carrying out vital research into treatments and vaccines for COVID-19, including clinical trials
identifying COVID-19 trends and risks to public health
diagnosing and monitoring the effects of COVID-19
controlling and helping to prevent the spread of the virus
planning and providing health, social care and other public services to the public
helping clinicians, scientists, public health bodies and the government to provide guidance and develop policies to respond to the outbreak
monitoring and managing the outbreak

Learning Disabilities Data (LDD)

Level of data - Aggregated

Frequency - Annual

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

An annual collection of data about learning disabilities in general practice. The data is used to support improved commissioning and delivery of healthcare for people with learning disabilities. The key benefit NHS England expects to achieve is improved data which will provide a spur to improve the quality of healthcare for people with learning disabilities. This is expected to follow over a time span of four to five years with regular annual data collection and publication.

The collection of data aims to:

• improve the health of (and reduce health inequalities experienced by) people with learning disabilities in England
• help people who commission services make better use of information.

The LDD extract enables NHS England to:

• make information about the health and healthcare for people with learning disabilities more readily available and understandable
• undertake detailed secondary analyses of existing data sets to identify important new lessons for service improvement and development
• share the learning by working to ensure that key messages about best practice in providing healthcare for people with learning disabilities are widely understood
• improve available information by surveying data gaps and working to fill them.

National Diabetes Audit (NDA)

Level of data - Record-level

Frequency - Quarterly

Are patients who have registered a type 1 opt-out included? No

Purpose and benefits

The Secretary of State for Health and Social Care has directed NHS England to establish and operate a system for the collection and analysis of the NDA including the National Diabetes Audit Core Audit, which is part of the NDA programme of clinical audits. People with diabetes should receive annual care checks each year and should be achieving a target for their blood glucose, cholesterol and blood pressure values. These annual checks and targets are outlined in the National Institute for Health and Care Excellence (NICE) Clinical Guidelines and Quality Standards.

The main NDA, also known as the Core Audit, collects information from GP practices and specialist diabetes out-patient services to look at whether people with diabetes are receiving their annual care checks, achieving their treatment targets, achieving expected health outcomes and being offered and attending structured education.

Network Contract Direct Enhanced Services (NCD)

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

A five-year framework for GP contract reform to implement the NHS Long Term Plan, published in January 2019, describes significant investment in Primary Care Networks (PCNs) through NCD. As part of NCD, investment is being provided to support expansion of the primary care workforce and the implementation of seven national network service requirements between 2019-20 and 2023-24 through the Additional Roles Reimbursement Scheme (ARRS).

The purpose of the service is to support NHS England in meeting payments to providers of primary medical services. This service incentivises improved patient outcomes and provides the relevant management information to support practices and commissioners understand their performance and validate their achievement and payments.

The benefits of supporting this service for data are reduced burden on practices and commissioners and timely discharge of NHS England legal obligations.

PCN data will be collected via the General Practice Extraction Service (GPES). This data will be collected at GP practice level and then reported in the NHS Commissioning Support Unit's (CSU) Calculating Quality Reporting Service (CQRS) at both practice and PCN level.

Physical Health Checks for people with Severe Mental Illness (PHSMI)

Level of data - Record-level

Frequency

bi-annually for 2023 -2024 service
quarterly from 2024 - 2025 service onwards

Are patients who have registered a type 1 opt-out included? No

Purpose and benefits

Collection of GP practice data in connection with PHSMI. The extraction is needed because the data will:

help monitor health outcomes to understand whether delivery of physical health checks and follow-up interventions leads to improvements in physical health indicators in people with SMI over time, including whether any given patient retains improvements in subsequent annual health check cycles
inform whether current policy and practice exacerbates or reduces health inequalities, including an insight into which patient cohorts are accessing health checks and interventions, and whether these have the same impact in different cohorts
review whether different risk factors (for example SMI diagnosis, demographics, socioeconomic status, or frequency of contacts with primary and secondary care) can be utilised to inform risk stratification of physical health checks and determine the style or frequency of checks appropriate for various patient cohorts
assess and address local inequalities in access to and uptake of physical health checks and interventions, informing a targeted approach to improve service provision on national and local levels
help understand the impact of health checks on healthcare utilisation and the subsequent cost effectiveness of delivery

Respiratory syncytial virus (RSV) – adults aged 75 and over- 2024-25

Level of data - Aggregated

Frequency - Monthly

Are patients who have registered a type 1 opt-out included? Yes

Purpose and benefits

This extract of data from GP clinical systems supports direct payment to GP practices under the GMS contract and provides management information to NHS England to support monitoring and understanding of the impact of the scheme on health outcomes.

The Joint Committee on Vaccination and Immunisation (JCVI) recommended the implementation of a new routine RSV single dose vaccination programme for older adults turning 75 years, who remain eligible for vaccination until their 80th birthday. The recommendations from JCVI will be implemented from 1 September 2024 for those turning 75 years on or after this date.